Amphastar Pharmaceuticals Inc (AMPH)
44.54
+0.45
(+1.02%)
USD |
NASDAQ |
Nov 21, 16:00
44.54
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Market Cap: 2.142B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.120B |
| November 19, 2024 | 2.097B |
| November 18, 2024 | 2.123B |
| November 15, 2024 | 2.145B |
| November 14, 2024 | 2.167B |
| November 13, 2024 | 2.187B |
| November 12, 2024 | 2.294B |
| November 11, 2024 | 2.335B |
| November 08, 2024 | 2.323B |
| November 07, 2024 | 2.216B |
| November 06, 2024 | 2.568B |
| November 05, 2024 | 2.479B |
| November 04, 2024 | 2.432B |
| November 01, 2024 | 2.439B |
| October 31, 2024 | 2.444B |
| October 30, 2024 | 2.456B |
| October 29, 2024 | 2.474B |
| October 28, 2024 | 2.487B |
| October 25, 2024 | 2.433B |
| October 24, 2024 | 2.401B |
| October 23, 2024 | 2.410B |
| October 22, 2024 | 2.437B |
| October 21, 2024 | 2.458B |
| October 18, 2024 | 2.459B |
| October 17, 2024 | 2.405B |
| Date | Value |
|---|---|
| October 16, 2024 | 2.459B |
| October 15, 2024 | 2.385B |
| October 14, 2024 | 2.384B |
| October 11, 2024 | 2.301B |
| October 10, 2024 | 2.239B |
| October 09, 2024 | 2.241B |
| October 08, 2024 | 2.239B |
| October 07, 2024 | 2.265B |
| October 04, 2024 | 2.260B |
| October 03, 2024 | 2.241B |
| October 02, 2024 | 2.249B |
| October 01, 2024 | 2.339B |
| September 30, 2024 | 2.348B |
| September 27, 2024 | 2.351B |
| September 26, 2024 | 2.344B |
| September 25, 2024 | 2.288B |
| September 24, 2024 | 2.320B |
| September 23, 2024 | 2.380B |
| September 20, 2024 | 2.408B |
| September 19, 2024 | 2.453B |
| September 18, 2024 | 2.437B |
| September 17, 2024 | 2.382B |
| September 16, 2024 | 2.369B |
| September 13, 2024 | 2.355B |
| September 12, 2024 | 2.278B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
585.38M
Minimum
Mar 20 2020
3.176B
Maximum
Aug 08 2023
1.531B
Average
1.393B
Median
Market Cap Benchmarks
| Eli Lilly and Co | 711.90B |
| BridgeBio Pharma Inc | 4.397B |
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
| iBio Inc | 22.42M |
Market Cap Related Metrics
| PE Ratio | 14.85 |
| PS Ratio | 3.231 |
| PEG Ratio | 0.8638 |
| Price to Book Value | 2.943 |
| Price to Free Cash Flow | 13.74 |
| Price | 44.54 |
| Earnings Yield | 6.74% |
| PEGY Ratio | 0.8638 |
| Operating PE Ratio | 10.91 |
| Normalized PE Ratio | 14.85 |